Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

NCT05336383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Plasma Cell Neoplasm
Malignant Plasma Cell Neoplasm

Interventions

DRUG: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center